David Virley

2.5k total citations
51 papers, 2.1k citations indexed

About

David Virley is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, David Virley has authored 51 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 13 papers in Neurology. Recurrent topics in David Virley's work include Neuroscience and Neuropharmacology Research (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (12 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). David Virley is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (12 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). David Virley collaborates with scholars based in United Kingdom, United States and Ireland. David Virley's co-authors include Neil Upton, A. Jackie Hunter, Elaine Irving, Tsu Tshen Chuang, Andrew A. Parsons, Sarah J. Hadingham, A. Jacqueline Hunter, Jill Richardson, Paul R. Nelson and Elena Jazin and has published in prestigious journals such as Brain, Stroke and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David Virley

48 papers receiving 2.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Virley 755 689 495 467 339 51 2.1k
Nicole Mahy 896 1.2× 976 1.4× 728 1.5× 566 1.2× 504 1.5× 91 2.6k
Zhenghua Xiang 760 1.0× 459 0.7× 601 1.2× 434 0.9× 184 0.5× 84 2.9k
F. Block 777 1.0× 1.1k 1.7× 910 1.8× 419 0.9× 476 1.4× 99 2.6k
Cynthia A. Csernansky 701 0.9× 777 1.1× 447 0.9× 471 1.0× 190 0.6× 21 1.9k
Francisco-José Fernández-Gómez 911 1.2× 622 0.9× 364 0.7× 554 1.2× 270 0.8× 47 2.0k
Seok Joon Won 1.0k 1.4× 879 1.3× 881 1.8× 569 1.2× 402 1.2× 58 3.1k
Michela Tantucci 489 0.6× 824 1.2× 409 0.8× 302 0.6× 413 1.2× 46 1.8k
Hui Shen 952 1.3× 1.2k 1.7× 717 1.4× 379 0.8× 431 1.3× 62 3.0k
Florian Plattner 1.1k 1.4× 898 1.3× 232 0.5× 752 1.6× 207 0.6× 39 2.3k
Chandramohan Wakade 738 1.0× 501 0.7× 389 0.8× 340 0.7× 423 1.2× 43 2.2k

Countries citing papers authored by David Virley

Since Specialization
Citations

This map shows the geographic impact of David Virley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Virley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Virley more than expected).

Fields of papers citing papers by David Virley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Virley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Virley. The network helps show where David Virley may publish in the future.

Co-authorship network of co-authors of David Virley

This figure shows the co-authorship network connecting the top 25 collaborators of David Virley. A scholar is included among the top collaborators of David Virley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Virley. David Virley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cilia, Jackie, Jennifer Li, Mat D. Davis, et al.. (2025). Behavioral and transcriptomic effects of a novel cannabinoid on a rat valproic acid model of autism. Neuropharmacology. 273. 110450–110450.
2.
Porsolt, Roger D., Vincent Castagné, Eric Hayes, & David Virley. (2013). Nonhuman Primates: Translational Models for Predicting Antipsychotic-Induced Movement Disorders. Journal of Pharmacology and Experimental Therapeutics. 347(3). 542–546. 9 indexed citations
3.
Cowley, Thelma R., Rodrigo E. González-Reyes, Jill Richardson, et al.. (2012). The Age-related Gliosis and Accompanying Deficit in Spatial Learning are Unaffected by Dimebon. Neurochemical Research. 38(6). 1190–1195. 6 indexed citations
4.
Callaghan, Charlotte K., et al.. (2012). Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457. Neuropharmacology. 63(5). 890–897. 26 indexed citations
5.
6.
Chapman, Paul B., Gerard M.P. Giblin, Mark P. Healy, et al.. (2011). Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonist. Bioorganic & Medicinal Chemistry Letters. 21(18). 5568–5572. 20 indexed citations
7.
Richardson, Jill, et al.. (2010). Dietary manipulation and caloric restriction in the development of mouse models relevant to neurological diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(10). 840–846. 23 indexed citations
8.
Cowley, Thelma R., Joan B. O’Sullivan, Christoph W. Blau, et al.. (2010). Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP. Neurobiology of Aging. 33(1). 162–175. 51 indexed citations
9.
Upton, Neil, Tsu Tshen Chuang, A. Jackie Hunter, & David Virley. (2008). 5-HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease. Neurotherapeutics. 5(3). 458–469. 210 indexed citations
10.
11.
Strong, Anthony J., Patricia J. Anderson, Helena Watts, et al.. (2006). Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. Brain. 130(4). 995–1008. 164 indexed citations
12.
Quinn, Leann P., Tania O. Stean, Helen Chapman, et al.. (2006). Further validation of LABORAS™ using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration. Journal of Neuroscience Methods. 156(1-2). 218–227. 36 indexed citations
13.
Read, Simon & David Virley. (2005). Stroke genomics : methods and reviews. Humana Press eBooks. 1 indexed citations
14.
Virley, David. (2004). Choice, Methodology, and Characterization of Focal Ischemic Stroke Models: The Search for Clinical Relevance. Humana Press eBooks. 104. 19–48. 7 indexed citations
15.
Virley, David, et al.. (2004). Amyloid precursor protein mRNA levels in Alzheimer's disease brain. Molecular Brain Research. 122(1). 1–9. 43 indexed citations
16.
Virley, David, et al.. (2003). β-Secretase (BACE) and GSK-3 mRNA levels in Alzheimer’s disease. Molecular Brain Research. 116(1-2). 155–158. 55 indexed citations
17.
Hodges, Helen, Piotr Sowiński, David Virley, et al.. (2000). Functional Reconstruction of the Hippocampus: Fetal Versus Conditionally Immortal Neuroepithelial Stem Cell Grafts. Novartis Foundation symposium. 231. 53–69. 17 indexed citations
18.
Hunter, A. Jacqueline, David Virley, Paul R. Nelson, et al.. (2000). Functional assessments in mice and rats after focal stroke. Neuropharmacology. 39(5). 806–816. 276 indexed citations
19.
20.
Hodges, Helen, et al.. (1997). Cognitive Deficits Induced by Global Cerebral Ischaemia: Prospects for Transplant Therapy. Pharmacology Biochemistry and Behavior. 56(4). 763–780. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Mahy Breakdown of academic impact, for papers by Zhenghua Xiang Breakdown of academic impact, for papers by F. Block Breakdown of academic impact, for papers by Cynthia A. Csernansky Breakdown of academic impact, for papers by Francisco-José Fernández-Gómez Breakdown of academic impact, for papers by Seok Joon Won Breakdown of academic impact, for papers by Michela Tantucci Breakdown of academic impact, for papers by Hui Shen Breakdown of academic impact, for papers by Florian Plattner Breakdown of academic impact, for papers by Chandramohan Wakade
Rankless by CCL
2026